For those who read my previous post on the sick computer - the doctor thinks he has a diagnosis. I got fed up and reinstalled Windows from scratch which also means all the applications need to be reinstalled. Did the install last night and late this morning it still spontaneously rebooted when I clicked on the Start button.
But when I came back up it said indeed it detected a memory problem and finally pointed to a Microsoft memory test utility you can download. Running that for about an hour found one memory module (of two) had problems. I removed that one and it has been working fine (knock on wood).
So I'm finally installing programs again and ones I have not had available since swapping machines 2-3 months ago. I can then edit the website easily etc.
While I have a sec, I'd like to thank all the people who buy their books, etc. on Amazon through lytmphomainfo.net! The small income helps fund the expense I've incurred (like the massive heat sink I installed earlier to lower the temperature and the hosting fees). Nice to know it doesn't cost you all anything extra but derived from Amazon's corporate profits.
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...